PD/Cub |
liver weight to body weight ratio |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
liver mass |
male |
310 days
| 6 |
|
41.7 |
g/kg |
0.82 |
2.0 |
post excision weight measurement |
|
0.0 |
|
0 |
|
70217 |
1318 |
PD/Cub |
serum insulin level |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood insulin amount |
male |
310 days
| 6 |
|
0.12 |
mg/dl |
0.0 |
0.01 |
radioimmunoassay |
retroorbital plexus |
0.0 |
|
0 |
|
70278 |
1318 |
PD/Cub |
serum glucose level |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood glucose amount |
male |
307 days
| 6 |
|
88.94 |
mg/dl |
1.48 |
3.63 |
oral glucose tolerance test |
tail vein |
0.0 |
intragastric glucose |
0 |
min |
70238 |
1318 |
PD/Cub |
body weight |
control condition |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
body mass |
male |
300 days
| 6 |
|
376.9 |
g |
3.02 |
7.4 |
body weighing method |
|
0.0 |
|
0 |
|
70205 |
1318 |
PD/Cub |
serum uric acid level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood uric acid amount |
male |
300 days
| 6 |
|
66.6 |
umol/l |
0.57 |
1.4 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
|
0 |
|
70280 |
1318 |
PD/Cub |
blood glucose level area under curve (AUC) |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood glucose amount |
male |
300 days
| 6 |
|
15152.73 |
(mg/dl) x min |
298.39 |
730.91 |
oral glucose tolerance test |
tail vein |
0.0 |
intragastric glucose |
120 |
min |
70268 |
1318 |
PD/Cub |
blood glucose level area under curve (AUC) |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood glucose amount |
male |
307 days
| 6 |
|
15169.09 |
(mg/dl) x min |
239.01 |
585.45 |
oral glucose tolerance test |
tail vein |
0.0 |
intragastric glucose |
120 |
min |
70270 |
1318 |
PD/Cub |
serum glucose level |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood glucose amount |
male |
310 days
| 6 |
|
375.71 |
mg/dl |
12.6 |
30.86 |
oral glucose tolerance test |
tail vein |
0.0 |
intragastric glucose |
0 |
min |
70240 |
1318 |
PD/Cub |
blood glucose level area under curve (AUC) |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood glucose amount |
male |
310 days
| 6 |
|
57081.82 |
(mg/dl) x min |
512.91 |
1256.36 |
oral glucose tolerance test |
tail vein |
0.0 |
intragastric glucose |
120 |
min |
70272 |
1318 |
PD/Cub |
heart weight to body weight ratio |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
heart mass |
male |
310 days
| 6 |
|
3.4 |
g/kg |
0.41 |
1.0 |
post excision weight measurement |
|
0.0 |
|
0 |
|
70209 |
1318 |
PD/Cub |
body weight |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
body mass |
male |
310 days
| 6 |
|
352.9 |
g |
1.55 |
3.8 |
body weighing method |
|
0.0 |
|
0 |
|
70211 |
1318 |
PD/Cub |
serum triglyceride level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood triglyceride amount |
male |
300 days
| 6 |
|
178.76 |
mg/dl |
18.06 |
44.25 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
|
0 |
|
70213 |
1318 |
PD/Cub |
serum free fatty acids level |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
307 days
| 6 |
|
1.56 |
mmol/l |
0.04 |
0.1 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
|
0 |
|
70230 |
1318 |
PD/Cub |
serum uric acid level |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood uric acid amount |
male |
310 days
| 6 |
|
67.2 |
umol/l |
2.53 |
6.2 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
|
0 |
|
70284 |
1318 |
PD/Cub |
serum glucose level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood glucose amount |
male |
300 days
| 6 |
|
94.38 |
mg/dl |
2.96 |
7.26 |
oral glucose tolerance test |
tail vein |
0.0 |
intragastric glucose |
0 |
min |
70236 |
1318 |
PD/Cub |
body weight |
controlled sucrose content diet (for 7 days) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
body mass |
male |
307 days
| 6 |
|
398.0 |
g |
0.86 |
2.1 |
body weighing method |
|
0.0 |
|
0 |
|
70207 |
1318 |
PD/Cub |
serum triglyceride level |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood triglyceride amount |
male |
307 days
| 6 |
|
276.99 |
mg/dl |
43.35 |
106.2 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
|
0 |
|
70215 |
1318 |
PD/Cub |
serum uric acid level |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood uric acid amount |
male |
307 days
| 6 |
|
110.2 |
umol/l |
2.49 |
6.1 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
|
0 |
|
70282 |
1318 |
PD/Cub |
single kidney wet weight to body weight ratio |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
kidney mass |
male |
310 days
| 6 |
|
3.8 |
g/kg |
0.04 |
0.1 |
post excision weight measurement |
|
0.0 |
|
0 |
|
70286 |
1318 |
PD/Cub |
serum free fatty acids level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
300 days
| 6 |
|
1.05 |
mmol/l |
0.04 |
0.1 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
|
0 |
|
70228 |
1318 |
PD/Cub |
serum free fatty acids level |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
310 days
| 6 |
|
4.13 |
mmol/l |
0.12 |
0.3 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
|
0 |
|
70234 |
1318 |
PD/Cub |
serum triglyceride level |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood triglyceride amount |
male |
310 days
| 6 |
|
2412.4 |
mg/dl |
173.42 |
424.78 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
|
0 |
|
70219 |
1318 |
PD/Cub |
serum insulin level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood insulin amount |
male |
300 days
| 6 |
|
0.01 |
mg/dl |
0.0 |
0.0 |
radioimmunoassay |
retroorbital plexus |
0.0 |
|
0 |
|
70274 |
1318 |
PD/Cub |
serum insulin level |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood insulin amount |
male |
307 days
| 6 |
|
0.01 |
mg/dl |
0.0 |
0.0 |
radioimmunoassay |
retroorbital plexus |
0.0 |
|
0 |
|
70276 |
1318 |
PD/Cub |
epididymal fat pad weight to body weight ratio |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
epididymal fat pad mass |
male |
310 days
| 6 |
fat pad weight/100g body weight |
2.17 |
% |
0.08 |
0.2 |
post excision weight measurement |
|
0.0 |
|
0 |
|
70232 |
1318 |